|
The Board
- Chris Thiemermann
- Rod Flower
- Brendan Whittle
- Magdi Yaqoob
- Mauro Perretti
- Chandan Alam
Company Secretary
|
The Board
Professor Chris Thiemermann, MD, PhD, FMedSci
(Chairman & Chief Executive)
Chris Thiemermann, MD, PhD, FMedSci (Director since 1993, Chief
Executive Officer since 2003) is a Professor of Pharmacology at
Queen Mary University, London. After gaining a degree in medicine
with distinction in Cologne (Germany), he joined the Institute in
1997.
He is a leading expert in the pathophysiology and therapy of myocardial
infarction, renal failure and shock, and was a Senior Fellow of
the British Heart Foundation.
He is currently a Fellow of the Academy of Medical Sciences, a
Foreign Member of the Academy of Sciences of Portugal (Lisboa) and
a Member of the Institute of Directors. According to the Institute
of Scientific Information, Chris Thiemermann is one of the 100-most
cited pharmacologists in the world (based on citations in the past
20 years).
To contact Chris Thiemermann, please email CEO@williamharvey.co.uk.
|
|